Circulating Tumor Cells in Right- and Left-Sided Colorectal Cancer

Chiara Nicolazzo, Cristina Raimondi, Angela Gradilone, Alessandra Emiliani, Ann Zeuner, Federica Francescangeli, Francesca Belardinilli, Patrizia Seminara, Flavia Loreni, Valentina Magri, Silverio Tomao, Paola Gazzaniga
DOI: 10.3390/cancers11081042
PMID: 31344798

Abstract

Molecular alterations are not randomly distributed in colorectal cancer (CRC), but rather clustered on the basis of primary tumor location underlying the importance of colorectal cancer sidedness. We aimed to investigate whether circulating tumor cells (CTC) characterization might help clarify how different the patterns of dissemination might be relative to the behavior of left- (LCC) compared to right-sided (RCC) cancers. We retrospectively analyzed patients with metastatic CRC who had undergone standard baseline CTC evaluation before starting any first-line systemic treatment. Enumeration of CTC in left- and right-sided tumors were compared. The highest prognostic impact was exerted by CTC in left-sided primary cancer patients, even though the lowest median number of cells was detected in this subgroup of patients. CTC exhibit phenotypic heterogeneity, with a predominant mesenchymal phenotype found in CTC from distal compared to proximal primary tumors. Most CTC in RCC patients exhibited an apoptotic pattern. CTC in left-sided colon cancer patients exhibit a predominant mesenchymal phenotype. This might imply a substantial difference in the biology of proximal and distal cancers, associated with different patterns of tumor cells dissemination. The poor prognosis of right-sided CRC is not determined by the hematogenous dissemination of tumor cells, which appears to be predominantly a passive shedding of non-viable cells. Conversely, the subgroup of poor-prognosis left-sided CRC is reliably identified by the presence of mesenchymal CTC.

Keywords

colorectal cancer, sidedness, circulating tumor cells, epithelial-mesenchymal transition, prognosis, CellSearch®, ScreenCell®

Stay informed about our publications

Lastest publications

Isolation and profiling of single circulating tumor cells in myeloma: a new workflow for liquid biopsies.

Liquid biopsy in breast cancer: Redefining precision medicine

Optimizing Detection of Circulating Tumor Cells in Breast Cancer: Unveiling New Markers for Clinical Applications

A project on circulating tumor cells?

From isolation to downstream analysis, ScreenCell® adapts to each step.

Follow ScreenCell on